MLAB vs MMM
MLAB: Mesa Laboratories provides essential quality control and life sciences tools designed to protect patient safety and ensure regulatory compliance in highly regulated healthcare and pharmaceutical markets. MMM: 3M is a diversified industrial manufacturer spanning safety, healthcare, transportation, and consumer products through decades of materials science innovation and global distribution.
Side-by-side fundamentals
| Metric | MLAB | MMM | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $126.06 | $163.58 | |
| Market cap | $705M | $84.4B | |
| P/E as of 2026-10-08 | 104.39 | 29.04 | MMM lower |
| Net margin | +2.7% | +13.0% | MMM higher |
| Gross margin FY2026, SEC XBRL | +63.5% | n/a | |
| Operating margin | +7.4% | +18.6% | MMM higher |
| ROE | +3.6% | +68.5% | MMM higher |
| ROA | +1.6% | +8.6% | MMM higher |
| Debt / equity as of 2026-09-03 | 0.81 | 4.25 | MLAB lower |
| Revenue growth (YoY) as of 2026-09-03 | +3.4% | +2.4% | MLAB higher |
| Revenue CAGR (3y) SEC XBRL | +4.4% | -1.6% | MLAB higher |
| Dividend yield as of 2026-09-03 | +0.5% | +1.9% | MMM higher |
| Dividend streak (yrs) SEC XBRL | 8 | 1 | MLAB higher |
| Beta as of 2026-09-03 | 1.43 | 0.97 | |
| 1-year return as of 2026-10-08 close | +78.2% | +4.9% | MLAB higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.